MethyLight

Peter Laird of the Keck School of Medicine of USC developed MethyLight technology, which is employed in Epigenomics AG’s proColon screening test that provides early detection of colon cancer with a simple blood draw. Epigenomics is also currently developing similar tests based on this technology for the early detection of prostate and lung cancer.